Daniel J George MD

PubMed

• 3 citations
  Prognostic and predictive analyses of circulating plasma biomarkers in men with metastatic castration resistant prostate cancer treated with docetaxel/prednisone with ...
  Andrew B Nixon, Yingmiao Liu, Qian Yang, Bin Luo, Mark D Starr
  Prostate Cancer and Prostatic Diseases. 2025-06-01
• Updated 5-year results for short course abiraterone acetate and LHRH agonist for unfavorable intermediate and favorable high-risk prostate cancer.
  Ryan E Fecteau, Bridget F Koontz, Karen E Hoffman, Susan Halabi, Lauren E Howard
  Prostate Cancer and Prostatic Diseases. 2025-06-01
• 7 citations
  A Call for a Neoadjuvant Kidney Cancer Consortium: Lessons Learned from Other Cancer Types.
  Axel Bex, Michael Jewett, Bryan Lewis, E Jason Abel, Laurence Albiges
  European Urology. 2025-04-01

Journal Articles

• Survuval Outcomes of Sipuleucel-T Phase 3 Studies: Impact of Control Arm Cross-over to Salvage Immunotherapy  
  George DJ, Nabhan C, DeVries T, Whitmore JB, Gomella LG, Cancer Immunol Res, 1/5/2016
• Clinical Trial Participants with Metastatic Renal Cell Carcinoma Differ From Patients treated in Real-World Practice  
  Mitchell AP, Harrison MR, Walker MS, George DJ, Abernethy AP, Hersch BR, J Oncol Pract, 1/1/2016
• Trial Design and objectives for castration-resistant prostate cancer: Updated recommendations from the prostate cancer clinical trials working group 3  
  Scher HI, Morris MJ, Stadler WM, Higano C, Basch E, Fizazi K, Antonarakis ES, Beer TM, Carducci MA, Chi KN, Corn PG, de Bono JS, Dreicer R, George DJ, Heath EI, Hussai..., J Clin Oncol, 1/1/2016

Books/Book Chapters

• Management of Castration Resistant Prostate Cancer 
  Chapter: Angiogenesis Inhibition in Castration-Resistant Prostate Cancer 
  George D, Kelly William, Mitchell AEditors: Fred Saad and Mario A Eisenberger.2014
• Oxford-American Handbook of Oncology 
  Chapter: Renal Cell Carcinoma 
  Mendiratta P, George DJ, Armstrong AJEditors: Gary Lyman.2009
• Renal Cell Carcinoma 
  Chapter: mTOR pathway biology in renal cell carcinoma 
  Kim W, Armstrong AJ, George DJEditors: Brian Rini and Steven Campbell.BC Decker, Inc., Ontario, CanadaEdition 1st,2009

Abstracts/Posters

• A phase II trial of temsirolimus in men with castration-resistant metastatic prostate cancer
  Armstrong AJ, Shen T, Halabi S, Kemeny G, Bitting RL, Kartcheske P, Embree E, Morris K, Winters C, Jaffe T, Fleming MT, George DJ, Journal of Clinical Oncology, Genitourinary Cancers Symposium, 1/1/2013
• Isolation of circulating tumor cells using a novel EMT-based capture method
  Bitting RL, Boominathan R, Rao C, Embree E, George DJ, Connelly MC, Kemeny G, Garcia-Blanco M, Armstrong AJ, Journal of Clinical Oncology, 1/1/2012
• A randomized, controlled phase III global trial comparing sipuleucel-T plus androgen deprivation therapy versus androgen deprivation therapy alone in men with metastat...
  Fizazi K, Powles T, George DJ, Poehlein CH, ASCO Annual Meeting, Journal of Clinical Oncology, 1/1/2011

Lectures

• Extending Survival in Kidney Cancer: The New Reality 
  Chicago, IL - 1/1/2016
• Prostate, Colon and smoking cessation 
  Durham, NC - 1/1/2016
• Duke Cancer Institute’s approach to prostate cancer screening and implementation of an active surveillance program: Doing the right thing for our patients 
  Durham, NC - 1/1/2015

Other

• Immunotherapy of renal cell carcinoma 
  George D, Jonasch E
  http://www.uptodate.com/contents/immunotherapy-of-renal-cell-carcinoma
  UpToDate, Wolters Kluwer Health - 2012-09-17